GET DAILY SIGNALSChurch & Dwight (CHD) vs Procter & Gamble (PG): Growth Potential Meets Dividend Reliability
Key Takeaways
- CHD operates as a mid-cap player in household and personal care with quicker organic expansion, whereas PG stands as a large-cap staples leader known for its scale and consistent dividend payouts.
- CHD posted around 5% organic sales growth in the latest quarter, fueled by innovation and volume gains even though reported revenue stayed flat due to portfolio adjustments.
- PG achieved low-single-digit organic sales growth for fiscal 2026, almost all of it coming from price increases instead of volume gains.
- PG provides a higher dividend yield along with a 136-year streak of payouts, while CHD presents a growth-focused profile on a more modest scale.
- Both companies navigate cost pressures, tariffs, and consumer shifts toward lower-priced options, yet CHD has demonstrated stronger recent relative momentum.
Why These Two Stocks Draw Comparison
Investors often place Church & Dwight alongside Procter & Gamble because the two companies share space in the household and personal care area of consumer staples, though they sit in quite different spots. This comparison matters for those balancing growth prospects with stability and momentum against reliable income. PG ranks among the largest consumer packaged goods firms globally, while CHD serves as a smaller yet agile rival. Examining their performance, positioning, and risk factors can clarify which one aligns better with specific portfolio goals in today’s environment. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Church & Dwight Overview and Recent Results
Church & Dwight, recognized for its Arm & Hammer line plus brands including TheraBreath, Hero, Trojan, and OxiClean, is a mid-sized staples company with a market capitalization near $23 billion. In its most recent quarter, the firm recorded about $1.47 billion in net sales, essentially unchanged from a year earlier, while adjusted EPS exceeded consensus estimates. Reported revenue faced headwinds from strategic portfolio moves in 2025, but organic sales growth, which excludes acquisitions, divestitures, and currency, rose to roughly 5% on stronger volume. Recent trading has supported the shares, with CHD outpacing the S&P 500 for much of the year. Management kept full-year guidance intact for mid-single-digit organic sales growth and adjusted EPS expansion of about 5% to 8%, despite noting temporary commodity and transportation cost issues. Acquisitions like Touchland and ongoing product innovation have helped sentiment, though analysts point out that domestic growth has slowed in earlier periods and valuation deserves attention.
Procter & Gamble Overview and Recent Results
Procter & Gamble ranks as the largest consumer products company worldwide, with yearly sales above $87 billion and a market capitalization around $364 billion. Its lineup covers Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care, anchored by names such as Tide, Pampers, Gillette, and Crest. For fiscal 2026, revenue advanced about 3%, yet organic sales increased only around 1%, almost entirely from pricing rather than volume. In recent weeks, PG has attracted positive analyst commentary, including several price target increases and one upgrade tied to better U.S. e-commerce results. The company continues executing a multi-year portfolio and productivity plan, and it extended its dividend for a 70th straight year as part of a 136-year payout history. Guidance for fiscal 2027 remains measured, with organic sales growth projected at 1% to 3% and core EPS ranging from flat to 3%, amid roughly $1 billion in after-tax cost challenges.
Head-to-Head: Growth Drivers and Risk Profiles
From a business standpoint, PG leans on global scale, broad brand reach, and distribution across more than 20 billion-dollar brands in over 180 countries. CHD, in contrast, depends on a focused but expanding portfolio and an acquisition-led approach centered on fast-moving consumables. Growth paths differ as well: CHD has emphasized volume-led organic gains and recent deals, while PG has relied more on pricing and productivity gains. On momentum, CHD has posted stronger relative returns and a firmer organic sales path, whereas PG delivers lower beta, a higher yield, and steadier cash returns. Risk differences stand out: CHD carries more exposure to integration risks and its mid-cap valuation, while PG must address volume growth amid inflation and private-label competition. Both encounter sector-wide pressures from consumer trade-downs and tariff-related input costs.
AI Verdict on the Comparison
From the factors at hand, Tickeron’s AI would likely lean toward CHD right now. The stock’s quicker organic sales pickup, volume-supported growth, and better recent relative performance point to stronger trend consistency and positive momentum that quantitative models often favor. At the same time, PG holds clear advantages in stability, scale, and income features that suit a more defensive stance. The conclusion remains probabilistic: if growth momentum and catalysts take priority, CHD holds the advantage, but a move toward caution or income emphasis could shift preference back to PG.
AI Tools in Everyday Research
In my own work, I turn to Tickeron’s AI Trading Bots when evaluating how automated strategies might handle names like these two staples stocks. The platform offers a range of bots with different styles and risk levels, updated for current conditions, which helps confirm whether momentum signals align with manual analysis. This step adds a useful layer without replacing core fundamental review.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
PG in -1.15% downward trend, sliding for three consecutive days on November 06, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where PG declined for three days, in 116 of 275 cases, the price declined further within the following month. The odds of a continued downward trend are 42%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
PG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Bullish Trend Analysis
The Momentum Indicator moved above the 0 level on October 06, 2026. You may want to consider a long position or call options on PG as a result. In 37 of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 43%.
The Moving Average Convergence Divergence (MACD) for PG just turned positive on October 07, 2026. Looking at past instances where PG's MACD turned positive, the stock continued to rise in 21 of 46 cases over the following month. The odds of a continued upward trend are 46%.
The 50-day moving average for PG moved above the 200-day moving average on October 16, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
Following a +1.97% 3-day Advance, the price is estimated to grow further. Considering data from situations where PG advanced for three days, in 156 of 349 cases, the price rose further within the following month. The odds of a continued upward trend are 45%.
The Aroon Indicator entered an Uptrend today. In 86 of 253 cases where PG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 34%.
Fundamental Analysis (Ratings)
The Tickeron Price Growth Rating for this company is 19 (best 1 - 100 worst), indicating outstanding price growth. PG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 33 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 36 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 86, placing this stock slightly better than average.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of 81 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.204) is normal, around the industry mean (21.731). P/E Ratio (24.504) is within average values for comparable stocks, (16.288). PG's Projected Growth (PEG Ratio) (3.813) is slightly higher than the industry average of (1.518). Dividend Yield (0.026) settles around the average of (0.032) among similar stocks. P/S Ratio (4.092) is also within normal values, averaging (1.902).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a provider of branded consumer packaged goods
Industry HouseholdPersonalCare
Advertisement